Lincoln Pharmaceuticals Ltd. - Research Center
531633 LINCOLN Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 147.28 | 142.49 | 146.45 | 155.99 | 135.62 |
| Operating profit | 22.73 | 18.38 | 29.66 | 31.15 | 20.72 |
| Interest | 0.44 | 0.50 | 0.15 | 0.39 | 0.41 |
| Gross profit | 32.70 | 24.90 | 40.52 | 39.45 | 27.99 |
| EPS (Rs) | 11.82 | 9.28 | 14.00 | 13.81 | 9.49 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 10.41 | 7.02 | 11.02 | 8.69 | 7.69 |
| Stock adjustment | 4.16 | 4.69 | -20.30 | 4.20 | 5.71 |
| Raw material | 52.75 | 51.89 | 56.88 | 49.66 | 42.70 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 29.02 | 25.05 | 26.44 | 24.94 | 26.47 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 38.62 | 42.48 | 53.77 | 46.03 | 40.03 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.22 | 2.69 | 2.81 | 2.58 | 2.55 |
| Taxation | 5.81 | 3.62 | 9.67 | 9.21 | 6.43 |
| Net profit / loss | 23.67 | 18.60 | 28.04 | 27.65 | 19.01 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 20.03 | 20.03 | 20.03 | 20.03 | 20.03 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 15.43 | 12.90 | 20.25 | 19.97 | 15.27 |
| GPM (%) | 20.74 | 16.66 | 25.73 | 23.95 | 19.53 |
| NPM (%) | 15.01 | 12.44 | 17.81 | 16.79 | 13.27 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis